CB-301

N/A

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameCB-301
Drug Alias NameCB-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-3 inhibitors
TargetsCaspase-3
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesCantabio Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A